Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections
Braz. j. infect. dis; 20 (2), 2016
Abstract Acute bacterial skin and skin structure infections are caused mainly by Gram-positive bacteria which are often treated with intravenous vancomycin, daptomycin, or linezolid, with potential step down to oral linezolid for outpatients. Tedizolid phosphate 200 mg once daily treatment for six days d...
Enfermedad Aguda, Antibacterianos/efectos adversos, Antibacterianos/farmacocinética, Antibacterianos/uso terapéutico, Método Doble Ciego, América Latina, Linezolid/efectos adversos, Linezolid/farmacocinética, Linezolid/uso terapéutico, Organofosfatos/efectos adversos, Organofosfatos/farmacocinética, Organofosfatos/uso terapéutico, Oxazoles/efectos adversos, Oxazoles/farmacocinética, Oxazoles/uso terapéutico, Enfermedades Cutáneas Bacterianas/tratamiento farmacológico, Enfermedades Cutáneas Bacterianas/metabolismo, Resultado del Tratamiento